Pharmacogenetic Testing in an Academic Psychiatric Clinic: A Retrospective Chart Review.

ABSTRACT: Pharmacogenomic (PGx) testing is being increasingly recognized by clinicians as an essential tool to guide medication decisions for treatment of psychiatric illnesses. Extensive implementation of PGx testing, however, varies by setting and location. In this retrospective study, we reviewed charts from 592 patients diagnosed with a psychiatric disorder at the Loyola University Medical Center, for whom PGx testing was performed. Information collected included demographics at the time of testing, psychiatric diagnosis, medical and psychiatric history and medications prior and after PGx testing. Of the 592 charts analyzed, the most common primary diagnoses were depression (52%) and anxiety (12%). Prior to PGx testing, 72% of patients were prescribed three or more medications, whereas, after te

SUBMITTER: Brown L 

PROVIDER: S-EPMC8470368 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature